Examining the Effectiveness of Multiwave Locked System Laser Treatment in Chronic Low Back Pain
1 other identifier
interventional
110
1 country
1
Brief Summary
Patients who come to Tavşanlı Assoc. Prof. Dr. Mustafa Kalemli State Hospital, Physical Therapy, and Rehabilitation Department who have been diagnosed with Chronic Low Back Pain by a physician will be included. Patients will be divided into two groups by the physician: conservative treatment and patients whose treatment program is determined as multi-wave locked system laser treatment in addition to conservative treatment. Pain intensity will be measured with a numerical pain rating scale. The Roland-Morris disability questionnaire will be used to evaluate the functionality of the participants, and the esthesiometer will be used to assess tactile acuity. Pressure pain threshold will be evaluated with the MicroFET 2 device. The Turkish Form of the SF-12 Quality of Life Scale will be used to assess the participants' quality of life. Pittsburgh's sleep quality index will be used to evaluate sleep quality. Patient satisfaction will be evaluated with a numerical rating scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Oct 2024
Typical duration for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedMarch 5, 2025
July 1, 2024
7 months
July 31, 2024
March 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
pain intensity
Numerical Pain Rating Scale: Ratings from 0 to 10 range from no pain to the highest pain level imaginable. Studies show that a 2-point change in the evaluation made with this scale indicates a clinically significant change beyond the limits of measurement error.Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Through study completion, an average of 1 year
Secondary Outcomes (6)
Functionality
Through study completion, an average of 1 year
Tactile Acuity
Through study completion, an average of 1 year
Pressure Pain Thereshold
Through study completion, an average of 1 year
Assessment of Quality of life
Through study completion, an average of 1 year
Sleep Quality
Through study completion, an average of 1 year
- +1 more secondary outcomes
Study Arms (2)
Conventional treatment group
ACTIVE COMPARATORIn conventional treatment, Hot Pack, TENS, therapeutic ultrasound and exercise program will be given by the hospital staff.
Conventional treatment + Multiwave Locked System Laser treatment group
EXPERIMENTALMultiwave-locked system laser treatment will be applied by the hospital staff to the group in addition to conventional treatment.
Interventions
Hot Pack, TENS, therapeutic ultrasound, and exercise
Hot Pack, TENS, therapeutic ultrasound, and exercise + multi-wave locked system laser treatment
Eligibility Criteria
You may qualify if:
- Being between the ages of 18-65
- Volunteering to participate in the study
- Having low back pain that has persisted for at least 3 months
You may not qualify if:
- History of surgery in the waist area
- Discopathy at a different level of the spine (Modic Type 3)
- Presence of tumor in the spine
- Infection in the discs
- Having an inflammatory disease
- Presence of neurological involvement
- Fracture
- Spondylosis
- Spinal Stenosis
- Spondylolisthesis
- Radiculopathy
- Having received treatment for low back pain in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Health Sciences University
Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Meltem Işıntaş
Kutahya Health Sciences University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2024
First Posted
September 19, 2024
Study Start
October 9, 2024
Primary Completion
May 1, 2025
Study Completion
August 1, 2026
Last Updated
March 5, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share